The Vanguard Group Reports Stake in Avadel Pharmaceuticals

The Vanguard Group, Inc. has disclosed its holding in Avadel Pharmaceuticals plc as per Rules 8.3 of The Irish Takeover Panel Act. According to the document filed, the disclosure highlights Vanguard's interest in Avadel's US$0.01 ordinary shares. As of 15 December 2025, Vanguard's position consisted of 5,657,451 shares, representing a 5.81% stake in the company.

This disclosure includes details of a recent transaction where The Vanguard Group purchased 50,765 shares at a price of 21.42 USD per share. There were no activities reported under cash-settled or stock-settled derivative transactions, nor were there any agreements or arrangements regarding these securities.

No other dealing arrangements, indemnities, or attached supplemental forms were indicated in the disclosure. Vanguard’s transparency reflects compliance with the Irish Takeover Rules, providing stakeholders with pertinent ownership information.